{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:00:04Z","timestamp":1794650404979,"version":"4.9.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute portal vein thrombosis is a rare medical event usually seen in liver disease, but it can also occur due to any inherited or acquired procoagulable state that triggers venous occlusion. Hormonal therapies have been associated with an increased risk of prothrombotic states. This case report documents a\u00a0portomesenteric\u00a0venous thrombosis in a postmenopausal woman with testosterone implant for the treatment of hypoactive sexual desire and discusses the importance of identifying hypercoagulable risk factors before initiating hormone replacement therapy. We want to improve the awareness of an unusual medical complication associated with hormone replacement therapy and shed light on how testosterone implants could facilitate a thrombotic event related to other risk factors such as obesity and chronic hypoxic states, as well as the importance of differential diagnosis in the evaluation of postmenopausal women on testosterone replacement therapy presenting with acute abdominal pain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 55-year-old obese postmenopausal Hispanic female with medical history of chronic obstructive pulmonary disease presents with intractable abdominal pain, is found to have elevated hemoglobin and hematocrit, and an abdominopelvic computed tomography scan revealing portal and superior mesenteric vein thrombosis. Further evaluation excluded inherited and acquired thrombophilia but revealed elevated testosterone levels. The patient was treated with anticoagulation, which resulted in recanalization of the portal and superior mesenteric veins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Supraphysiologic levels of testosterone caused by testosterone implants as a treatment of hypoactive sexual desire in postmenopausal women can contribute to thrombotic events in the presence of additional prothrombotic risk factors. Therefore, testosterone therapy should include a thorough risk assessment for prothrombotic states, be tailored to patients\u2019 physiologic testosterone levels, and have close follow-up with testosterone level monitoring.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02805-6","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T10:02:52Z","timestamp":1621418572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Portomesenteric venous thrombosis in a postmenopausal female with testosterone implant: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-415X","authenticated-orcid":false,"given":"Monica Zanconato","family":"Campitruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis T.","family":"Ortiz-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"2805_CR1","doi-asserted-by":"publisher","first-page":"bcr2014206023","DOI":"10.1136\/bcr-2014-206023","volume":"21","author":"H Katz","year":"2014","unstructured":"Katz H, Popov E, Bray N, Berman B. Mesenteric vein thrombosis caused by secondary polycythemia from AndroGel. BMJ Case Rep. 2014;21:bcr2014206023.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2805_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jceh.2014.12.008","volume":"51","author":"YK Chawla","year":"2015","unstructured":"Chawla YK, Bodh V. Portal vein thrombosis. Rev J Clin Exp Hepatol. 2015;51(1):22\u201340.","journal-title":"Rev J Clin Exp Hepatol"},{"issue":"6","key":"2805_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/cld.336","volume":"3","author":"S Seijo","year":"2014","unstructured":"Seijo S, Plessier A. Noncirrhotic nontumoral portal vein thrombosis. Clin Liver Dis (Hoboken). 2014;3(6):118\u201321.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2805_CR4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1053\/jhep.2000.16597","volume":"32","author":"B Condat","year":"2000","unstructured":"Condat B, Pessione F, et\u00a0al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466\u201370.","journal-title":"Hepatology"},{"key":"2805_CR5","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1007\/s00268-011-1198-0","volume":"35","author":"TC Hall","year":"2011","unstructured":"Hall TC, Garcea G, Metcalfe M, Bilku D, Dennison AR. Management of acute non-cirrhotic non-malignant portal vein thrombosis: a systematic review. World J Surg. 2011;35:2510\u201320.","journal-title":"World J Surg"},{"issue":"4","key":"2805_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0036933013508043","volume":"58","author":"DG Watt","year":"2013","unstructured":"Watt DG, Shapter O, Mittapalli D, Murray WG. Massive mesenteric and portal venous thrombosis secondary to hormone replacement therapy. Scott Med J. 2013;58(4):80\u2013100.","journal-title":"Scott Med J"},{"key":"2805_CR7","doi-asserted-by":"publisher","first-page":"495863","DOI":"10.1155\/2009\/495863","volume":"2009","author":"DM Mintzer","year":"2009","unstructured":"Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009;2009:495863.","journal-title":"Adv Hematol"},{"key":"2805_CR8","first-page":"427","volume":"5","author":"N Bassil","year":"2009","unstructured":"Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag. 2009;5:427\u201348.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"2805_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm8010011","volume":"8","author":"CJ Glueck","year":"2018","unstructured":"Glueck CJ, Goldenberg N, Wang P. Testosterone therapy, thrombophilia, venous thromboembolism, and thrombotic events. J Clin Med. 2018;8(1):11. https:\/\/doi.org\/10.3390\/jcm8010011.","journal-title":"J Clin Med"},{"issue":"5","key":"2805_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13697137.2019.1637079","volume":"22","author":"SR Davis","year":"2019","unstructured":"Davis SR, et\u00a0al. Global consensus position statement on the use of testosterone therapy for women. Climacteric. 2019;22(5):429\u201334. https:\/\/doi.org\/10.1080\/13697137.2019.1637079.","journal-title":"Climacteric"},{"key":"2805_CR11","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cgh.2008.07.031","volume":"6","author":"J Turnes","year":"2008","unstructured":"Turnes J, et\u00a0al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol. 2008;6:1412\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2805_CR12","doi-asserted-by":"publisher","first-page":"i5968","DOI":"10.1136\/bmj.i5968","volume":"355","author":"C Martinez","year":"2016","unstructured":"Martinez C, et\u00a0al. Testosterone treatment and risk of venous thromboembolism: population-based case-control study. BMJ. 2016;355:i5968.","journal-title":"BMJ"},{"key":"2805_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1076029612460425","volume":"19","author":"O Nadeem","year":"2013","unstructured":"Nadeem O, Gui J, Ornstein DL. Prevalence of venous thromboembolism in patients with secondary polycythemia. Clin Appl Thromb Hemost. 2013;19:4. https:\/\/doi.org\/10.1177\/1076029612460425.","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02805-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T10:04:15Z","timestamp":1621418655000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02805-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2805"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02805-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"16 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}